Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002007191-24-000008
Filing Date
2024-12-30
Accepted
2024-12-30 16:05:17
Documents
5
Period of Report
2024-12-29

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS f6K30Dec24.htm 6-K 10300
2 EX-99.1 zircaix.htm EX-99.1 16264
3 EX-99.2 cbrem.htm EX-99.2 18430
4 GRAPHIC image1-1.gif GRAPHIC 35096
5 GRAPHIC image1.gif GRAPHIC 35096
  Complete submission text file 0002007191-24-000008.txt   142988
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42128 | Film No.: 241589758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)